Skip to main content

Alimera Sciences Inc(ALIM-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time

Alimera Sciences Reports Fourth Quarter and FY 2021 Results

Globe Newswire - Thu Feb 24, 2022

Fourth Quarter Highlights:

Full Year 2021 Highlights:

ATLANTA, Feb. 24, 2022 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) (Alimera), a global pharmaceutical company whose mission is to be invaluable to patients, physicians and partners concerned with retinal health and maintaining better vision longer, today announced financial results for the fourth quarter and full year 2021. Alimera will host a conference call on February 24, 2022, at 9:00 a.m. ET to discuss these results and provide an update on corporate developments.

Read more at globenewswire.com

Provided Content: Content provided by Globe Newswire. The Globe and Mail was not involved, and material was not reviewed prior to publication.

More from The Globe